Recall of Device Recall AntiHBC EIA

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Bio-Rad Laboratories.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    46728
  • Event Risk Class
    Class 2
  • Event Number
    Z-1189-2008
  • Event Initiated Date
    2008-01-07
  • Event Date Posted
    2008-08-20
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2011-03-07
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
  • Reason
    Incorrect result: elevated reactivity with a kit lot 232bgg. patient samples that are negative for antibodies to anti-hbc could be assigned a positive result.
  • Action
    Bio-Rad called each customer and alerted them to the issue on 1/7-8/2008. A letter was faxed and sent via overnight carrier (DHL) to each customer site on 1/8/2008. Customers were told not to use the affected lot of the product and to discard it. The firm will provide another lot of the product to customers.

Device

  • Model / Serial
    Lot Number 232BGG
  • Distribution
    Nationwide Distribution.
  • Product Description
    Bio-Rad MONOLISA Anti-HBc EIA, Catalog Number 26186. In vitro diagnostic.
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Bio-Rad Laboratories, 6565 185th Ave NE, Redmond WA 98052-5039
  • Manufacturer Parent Company (2017)
  • Source
    USFDA